Abstract
A growing body of evidences indicates the role of increased glucose variability (GV) as an independent cardiovascular risk factor in diabetes. It has been shown that high GV is associated with coronary and carotid atherosclerosis in diabetic subjects. The impact of enhanced glycemic fluctuations on vascular wall is mediated through non-enzymatic glycation, oxidative stress, activation of inflammatory pathways, and endothelial dysfunction. Thus, the effects of high GV exacerbate the influence of chronic hyperglycemia. The FinnDiane study established existence of a relationship between glycated hemoglobin (HbA1c) variability and cardiovascular events (myocardial infarction, coronary artery procedure including by-pass surgery or angioplasty, stroke, limb amputation because of ischemia, or a peripheral artery procedure) in patients with type 1 diabetes. In ADVANCE study visit-to-visit HbA1c and fasting glucose variability was associated with cardiovascular events in type 2 diabetic subjects; moreover, HbA1c variability was associated with all-cause mortality. In Verona Diabetes Study, fasting GV was predictor of cardiovascular mortality in elderly patients with type 2 diabetes. In-hospital glycemic excursions in patients with acute myocardial infarction and in diabetic patients undergoing percutaneous coronary intervention predict the risk of adverse cardiac events. The episodes of hypoglycemia in diabetic patients with high GV may contribute to an increased risk of arrhythmias, myocardial ischemia and infarction, and stroke. The data presented give support to notion that GV could be considered a new therapeutic target in patients with diabetes and cardiovascular disease.
Highlights
A growing body of evidences indicates the role of increased glucose variability
It has been shown that high glucose variability (GV) is associated with coronary
The impact of enhanced glycemic fluctuations on vascular wall is mediated through non-enzymatic glycation
Summary
A growing body of evidences indicates the role of increased glucose variability (GV) as an independent cardiovascular risk factor in diabetes. При восстановлении нормального уровня глюкозы у больных СД 1‐го типа и здоровых лиц выраженность окислительного стресса уменьшалась, при индукции гипергликемии свободнорадикальные процессы еще более усиливались [15]. У больных СД 2‐го типа показаны корреляции между уровнем вч-СРБ, средней амплитудой колебаний гликемии и вариабельностью уровня HbA1c в течение 2 лет [22]. У больных СД 1‐го типа изменения уровня глюкозы в диапазоне 5–15 ммоль / л (каждые 6 ч на протяжении суток) приводили к более выраженному нарушению эндотелийзависимой вазодилатации по сравнению с таковым при стабильной гипергликемии (10 и 15 ммоль / л) [23]. Роль ВГ в патогенезе сосудистых осложнений СД реализуется через усиление процессов гликирования, свободнорадикального окисления, активацию воспалительных сигнальных путей, развитие дисфункции эндотелия.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
